Invesco
SLS icon

Invesco’s SELLAS Life Sciences SLS Stock Holding History

Invesco’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.54M Sell
375,342
-322,738
-46% -$2.23M ﹤0.01% 2192
2026
Q1 		$2.95M Buy
698,080
+644,787
+1,210% +$2.88M ﹤0.01% 2388
2025
Q4 		$201K Buy
53,293
+3,114
+6% +$6.05K ﹤0.01% 3531
2025
Q3 		$80.8K Buy
50,179
+13
+0% +$23 ﹤0.01% 3712
2025
Q2 		$110K Buy
+50,166
New +$77K ﹤0.01% 3642

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Invesco's SLS Position: Q2 2026 in Review

Invesco reduced its SELLAS Life Sciences (SLS) stake by 46% in Q2 2026, selling an estimated $2.23M and leaving 375,342 shares worth $5.54M. The position accounts for ﹤0.01% of the portfolio, ranked #2192.

Invesco first reported a position in SLS in Q2 2025 and has held it in 5 quarters since. 193 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Invesco held 375,342 shares of SELLAS Life Sciences worth $5.54M as of Q2 2026.
  • Invesco sold 322,738 SELLAS Life Sciences shares in Q2 2026, an estimated $2.23M.
  • SELLAS Life Sciences made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #2192 holding.
  • Invesco first reported a position in SELLAS Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • 193 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.